Pharmaceuticals, Biotechnology and Life Sciences
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3…
RAHWAY, N.J., & NUTLEY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that preliminary clinical data from a…
SYDNEY, Australia and NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) — EnGeneIC, an innovative biopharmaceutical company leading the field of…
REDWOOD CITY, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today announced that McDavid Stilwell, Chief…
DUBLIN–(BUSINESS WIRE)–ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Moody’s Investors Service (“Moody’s”)…
Clinical data on lead program, nula-cel, demonstrating curative outcome in first treated patient with sickle cell disease (SCD) to be…
SAN FRANCISCO & SYDNEY–(BUSINESS WIRE)–ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tools, today announced…
Lead investigational candidate, MBRC-101, uniquely targets EphA5 receptor tyrosine kinase, which is present in multiple cancers, including breast, non-small cell…
DUBLIN–(BUSINESS WIRE)–The “Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment),…